[go: up one dir, main page]

TR201000732A2 - Pharmaceutical composition in dry powder form containing tiotropium and budesonide - Google Patents

Pharmaceutical composition in dry powder form containing tiotropium and budesonide

Info

Publication number
TR201000732A2
TR201000732A2 TR2010/00732A TR201000732A TR201000732A2 TR 201000732 A2 TR201000732 A2 TR 201000732A2 TR 2010/00732 A TR2010/00732 A TR 2010/00732A TR 201000732 A TR201000732 A TR 201000732A TR 201000732 A2 TR201000732 A2 TR 201000732A2
Authority
TR
Turkey
Prior art keywords
budesonide
pharmaceutical composition
dry powder
powder form
form containing
Prior art date
Application number
TR2010/00732A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/00732A priority Critical patent/TR201000732A2/en
Priority to PCT/TR2011/000014 priority patent/WO2011093812A2/en
Publication of TR201000732A2 publication Critical patent/TR201000732A2/en
Priority to US13/531,972 priority patent/US8834931B2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere,tiotropyum ve budesonid ve/veya bunların farmasötik olarak kabul edilebilir türevlerinin kombinasyonlarını içeren kum toz formundaki farmasötik kompozisyonlara ve bunları içeren blister formlarına ilişkindir.The present invention relates to pharmaceutical compositions in the form of sand powders containing combinations of tiotropium and budesonide and / or pharmaceutically acceptable derivatives thereof for use in respiratory disorders and to blister forms containing them.

TR2010/00732A 2009-12-25 2010-02-02 Pharmaceutical composition in dry powder form containing tiotropium and budesonide TR201000732A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2010/00732A TR201000732A2 (en) 2010-02-02 2010-02-02 Pharmaceutical composition in dry powder form containing tiotropium and budesonide
PCT/TR2011/000014 WO2011093812A2 (en) 2010-01-28 2011-01-28 Pharmaceutical formulation comprising tiotropium and budesonide in dry powder form
US13/531,972 US8834931B2 (en) 2009-12-25 2012-06-25 Dry powder formulation containing tiotropium for inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/00732A TR201000732A2 (en) 2010-02-02 2010-02-02 Pharmaceutical composition in dry powder form containing tiotropium and budesonide

Publications (1)

Publication Number Publication Date
TR201000732A2 true TR201000732A2 (en) 2011-08-22

Family

ID=44950393

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/00732A TR201000732A2 (en) 2009-12-25 2010-02-02 Pharmaceutical composition in dry powder form containing tiotropium and budesonide

Country Status (1)

Country Link
TR (1) TR201000732A2 (en)

Similar Documents

Publication Publication Date Title
IL268756B (en) Piperazine-2,5-dione derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
HUE060743T2 (en) Pharmaceutical compositions containing imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (PAR4) inhibitors for the treatment of platelet aggregation
CY1120605T1 (en) DRY POWDER PREPARATION INCLUDING A PHOSPHODIESTERATION INHIBITOR
IL235020A0 (en) N-phenyl benzenesulfonamide derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
TR201000680A2 (en) Pharmaceutical compositions containing tiotropium, formoterol and budesonide
IL223795A (en) Tetrahydro-pyrido-pyrimidine derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments
IL213517A (en) Sulfonamide derivatives, pharmaceutical compositions comprising them and uses thereof in the manufacture of medicaments
IL224288A (en) Derivatives of substituted pyrazolamide, pharmaceutical compositions comprising the same and uses thereof
TR201000681A2 (en) Dry powder formulations inhaled.
HUE040525T2 (en) Dry powder composition containing corticosteroid and beta-adrenergic agent for administration by inhalation
MX2015015132A (en) Inhalable pharmaceutical compositions and the inhaler devices containing them.
TR201000733A2 (en) Pharmaceutical compositions comprising fluticasone, tiotropium and sodium chromoglycate.
IL225105A (en) Heterocyclic compounds, process for their preparation, pharmaceutical compositions comprising them and use thereof for the preparation of medicaments
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
WO2011093818A3 (en) Pharmaceutical compositions comprising salmeterol and fluticasone
IN2013MU01177A (en)
MX2015009891A (en) Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy.
CL2015002702A1 (en) Micronized pharmaceutical compositions.
TR200907913A2 (en) Pharmaceutical composition in dry powder form for inhalation
TR201000732A2 (en) Pharmaceutical composition in dry powder form containing tiotropium and budesonide
TR200907914A2 (en) Pharmaceutical composition in the form of a dry powder containing corticosteroid.
TR201000729A2 (en) Pharmaceutical composition in dry powder form containing tiotropium and ciclesonide
WO2011093811A3 (en) Pharmaceutical preparations comprising formoterol and fluticasone
TR200907915A2 (en) Pharmaceutical composition in dry powder form.
TR201000731A2 (en) Pharmaceutical composition in dry powder form comprising tiotropium and fluticasone.